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The paramount relevance of protein phosphorylation in health and disease motivated us to gather
several contributions from experts working in this area in order to portray the recent develop-
ments in the field. Our effort and the effort of 54 authors with their 12 contributions gave rise
to this Research Topic, which represents a valuable forum where phosphorylation is discussed
from different angles, including bioinformatics approaches and experimental methods that are
currently used to decipher the complex mechanisms underlying this bewitching post-translational
modification (PTM). The articles collected in this Research Topic illustrate very diverse aspects of
phosphorylation, such as its biological effects and induced structural changes, the role of kinases
and phosphatases as therapeutic targets, the use of phosphorylation profiles as biomarkers, how
phosphorylation dys-regulation may cause disease, and more.
Nishi et al. (2014), in their extensive review of the representative studies on the biological effects
of phosphorylation, show that a general mechanism of regulation by phosphorylation does not
exist. Indeed, phosphorylation may serve as recognition/binding site or trigger allosteric effects
inducing local structural changes, whichmay propagate into larger structure rearrangements. Some
nice examples of the biological consequences of protein phosphorylation in physiological and
disease states are described in two articles of this Research Topic.
The Hsp27 protein (coded by the HSPB1 gene) is a chaperone that is aberrantly expressed in
many types of tumors and represents a promising drug target (Acunzo et al., 2014). Phosphory-
lation of serine residues affects the oligomerization state of Hsp27, favoring the recruitment of
different client proteins involved in distinct cellular functions (Katsogiannou et al., 2014a). Kat-
sogiannou et al. (2014b) suggest that better understanding Hsp27 phosphorylation dynamics in
cancer may help improve existing and/or develop new therapies.
Amata et al. (2014) report the interesting case of the role of phosphorylation events in the
Unique domain of Src family kinases (SFKs). This domain, an intrinsically disordered region little
conserved across the family and linking the kinase to its membrane-anchoring domain, is stubbed
with phosphosites involved in multilevel regulation of SFKs, including, among others, anchoring
to the lipid membrane.
These examples hint at the high complexity of the cellular networks regulated by phospho-
rylation. Kinases and phosphatases can be also regulated by phosphorylation and most of signal
transduction pathways involve cascades of phosphorylation and de-phosphorylation events. This
scenario should give the reader a glimpse of the consequences on entire pathways of the aboli-
tion or stimulation of phosphorylation caused, for instance, by mutational events. In this context,
the development of experimental and computational methods aimed at understanding the mecha-
nisms of specificity and functioning of kinase and phosphatase repertoires is becoming increasingly
relevant.
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A comprehensive review (Newman et al., 2014) presents a
broad picture on well established and emerging experimen-
tal methods that are providing new insights on the organiza-
tion and regulation of phosphorylation networks. Thanks to
these approaches, thousands of phosphorylation events have
been identified in distinct cellular conditions. Importantly,
these technological advances are stimulating the development of
computational models to gain a systems-level understanding of
phosphorylation maps (e.g., Linding et al., 2007; Song et al., 2012;
Newman et al., 2013).
A full comprehension of such maps requires the elucidation of
the molecular determinants of substrate recognition. The review
of Palmeri and collaborators summarizes the current knowl-
edge on kinase-substrate specificity (Palmeri et al., 2014), argu-
ing that only the combination of different sources of contextual
information will provide new insights into the molecular deter-
minants of kinase specificity and improve the performance of
kinase-substrate interaction prediction tools.
The understanding of kinase specificity is also particularly
relevant for the identification, design and development of com-
pounds modulating the kinase activity. In this context, reliable
computational methods for kinase/inhibitor inference and analy-
ses would play a crucial role. As pointed out by Ferrè et al. (2014),
such methods are being successfully developed and applied to the
whole kinome thanks to the increasing amount of homogeneous
data provided by high-throughput profiling studies.
Most inhibition screenings focus on compounds able to bind
the kinase catalytic site. However, on one hand, targeting the cat-
alytic site lacks specificity and, on the other, the modulation of
kinase activity can be achieved also through alternative routes.
An illustrative example, is presented by Gonfloni in a perspec-
tive article reviewing the current knowledge of c-Abl regulation
by allosteric compounds, such as GNF-2 (Gonfloni, 2014). The
author proposes that the use of current and novel allosteric acti-
vators will elucidate the role of c-Abl regulation in cancer and
neurodegenerative disorder signaling pathways.
This example suggests that rational drug design would
tremendously benefit from a better comprehension of kinase con-
formational changes and flexibility. Whilst experimental tech-
niques able to accurately describe such phenomena are still
under development, computational methods for the study of
kinase conformational transitions—especially Atomistic Molec-
ular Dynamics (MD)—demonstrated to be of great help. In their
minireview, D’Abramo et al. (2014) highlight that, since kinase
conformational switches from inactive to active states occur
on long time-scales, enhanced sampling techniques and brute-
force approaches are being developed and successfully applied to
rational drug design in a growing number of cases.
Despite phosphatases are key players in phosphorylation net-
works, they caught less attention than kinases as drug targets and
the identification of phosphatase physiological substrates is still
an open challenge (Brautigan, 2013).
In order to tackle this problem, Sacco and colleagues
(Sacco et al., 2014), in their original research article, present
computational an integrative approach combining functional
siRNA information (Sacco et al., 2012), interaction discovery
experiments and network analyses to identify phosphatase sub-
strates and potential scaffolds proteins that could mediate sub-
strate recognition. Their strategy was able to recover known as
well as novel phosphatase substrates/scaffolds, some of which
were further validated.
The growing knowledge of phosphatases and their substrates
is expanding the interest of the scientific community in these
enzymes as potential therapeutic targets in order to modulate
dys-regulated phosphorylation levels of disease proteins. One
example is provided by Taymans and Baekelandt (2014) who
review phosphorylation dys-regulation in the threemain proteins
linked to ParkinsonDisease: alpha-synuclein, Leucine-rich repeat
kinase type 2 (LRRK2), and microtubule associate protein tau
(tau). They analyze the feasibility of targeting their phosphatases
as a potential therapy for Parkinsonism.
Together with the study of kinases and phosphatases, the anal-
ysis of phosphorylation profiles is also important in developing
therapies or biomarkers for phosphorylation-related diseases.
In an original research article, Robertson and colleagues
(Robertson et al., 2014) describe an integrative approach to study
the honeybee (Apis mellifera) kinome with the aim of detect-
ing differences in phosphorylation profiles between bees with
differential susceptibility to Varroa mite infestation at different
developmental stages. They found that many peptides are differ-
entially phosphorylated between the two phenotypes and bioin-
formatics analyses showed clear differences between resistant and
susceptible phenotypes.
The evolution of PTMs and phosphorylation in particular, is
another key aspect of the story. In a minireview, Landry et al.
(2014) present recent evidences suggesting that clusters of sites
rather than individual sites represent functional units evolv-
ing under stabilizing selection. Nevertheless, more experimental
studies are needed to test whether the stabilizing selection model
applies to phosphosite clusters.
With the multifaceted description of protein phosphoryla-
tion presented in this Research Topic, we hope we provided the
readers with a taste of the huge complexity of phosphorylation
networks and pathways and convinced them that a deeper knowl-
edge of the interplay between kinases, phosphatases and their
substrates is essential in the quest for new disease biomarkers and
novel therapeutic targets.
Finally, we would like to thank all the authors for their piv-
otal contribution to this Research Topic, as well as the 25 peers
that acted as review editors and the Frontiers in Genetics Editorial
Office staff members for their support.
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